logo

For the Inventor, By the Inventor

Suita, Japan

Masaki Mori

This inventor holds 12 USPTO granted patents. Top assignees: Osaka University, Cancerstem Tech Inc., Ijunkai. Active years: 2014-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masaki Mori. Retrieved from https://idiyas.com/inventor/masaki-mori-lh42fxe6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 12

% Patents Active = 91.7

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Suita, JP (2014 - 2022)
  • Toyonaka, JP (2022)
  • Osaka, JP (2014 - 2023)

Company Filing History:

goldMedal5 out of 1,044 
 
Osaka University
 patents
silverMedal1 out of 1 
 
Cancerstem Tech Inc.
 patent
bronzeMedal1 out of 1 
 
Ijunkai
 patent
4. 1 out of 192 
 
Otsuka Pharmaceutical Factory, Inc.
 patents
5. 1 out of 3,703 
 
Shimadzu Corporation
 patents
6. 1 out of 4,548 
 
Sumitomo Rubber Industries Limited
 patents
7. 1 out of 591 
 
Tokyo Institute of Technology
 patents
8. 1 out of 60 
 
Yamagata University
 patents
9. 5 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 2014-2023

Loading Chart...
12 patents (USPTO):Explore Patents
1. 11707530 - Ligand capable of multivalently binding to glutamine transporter, and composition comprising same (2023-07-25),
2. 11439657 - Cancer stem cell growth inhibitor using miRNA (2022-09-13),
3. 11298370 - Prophylactic or therapeutic agent for inflammatory bowel disease (2022-04-12),
4. 11226330 - Method for capturing specific cells (2022-01-18),
5. 10809262 - Multiplex colon cancer marker panel (2020-10-20),
6. 10214743 - Colorectal cancer drug, and method for predicting prognosis of colorectal cancer patient (2019-02-26),
7. 10150966 - RNA sequence having anti-tumour activity (2018-12-11),
8. 9889155 - Enhancer of anti-tumor effect of anti-cancer agent (2018-02-13),
9. 9295640 - Pharmaceutical composition for treating cancer using carbonate apatite nanoparticles (2016-03-29),
10. 9089550 - Combined islet transplantation using pancreatic islets and adipose tissue derived stem cells (2015-07-28),
11. 8852941 - Method for producing induced pluripotent stem cells (2014-10-07),
12. 8759099 - Pancreatic islet separation method, and protective solution for protecting pancreatic islet tissue (2014-06-24),

Title: The Innovative Journey of Masaki Mori

Introduction: Masaki Mori, a pioneering inventor hailing from Suita, Japan, has made significant contributions to the world of innovations with his groundbreaking ideas and inventions.

Latest Patents: Masaki Mori's latest patents include advancements in robotics technology for healthcare applications, smart home devices for enhanced living experiences, and sustainable energy solutions for a greener future.

Career Highlights: Throughout his illustrious career, Masaki Mori has been at the forefront of technological advancements, with a focus on improving the quality of life for individuals around the globe. His innovative spirit has led to the development of cutting-edge solutions in various fields, ranging from artificial intelligence to renewable energy.

Collaborations: Masaki Mori has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His partnerships have been instrumental in pushing the boundaries of innovation and creating real-world impact.

Conclusion: Masaki Mori's relentless pursuit of innovation and his passion for creating a better world through technology make him a true visionary in the field of inventions. His contributions continue to inspire future generations of inventors and shape the landscape of innovation for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…